T1	Participants 105 172	patients with unresectable and/or recurrent advanced gastric cancer
T2	Participants 459 526	Patients with unresectable and/or recurrent advanced gastric cancer
T3	Participants 1001 1012	83 patients
T4	Participants 1651 1688	patients with advanced gastric cancer
